Dr Nick Linker (President, British Heart Rhythm Society)
Despite the need to implant more devices in patients and to develop new, innovative, devices there remain major obstacles. The recent report from the Cardiovascular Round Table4 highlights some of these barriers. Delays in implementation of guidelines, and in dissemination of new devices, vary throughout Europe, and are related to a number of factors such as funding, complex R&D lifecycles and regulatory issues. The cumulative result is inconsistent delivery both across Europe and within the UK. In Germany, hospitals can access an innovation fund set up by health insurers to exploit